1. Home
  2. ETON vs SDGR Comparison

ETON vs SDGR Comparison

Compare ETON & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$62.53

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

SDGR

Schrodinger Inc.

HOLD

Current Price

$19.91

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
SDGR
Founded
2017
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
ETON
SDGR
Price
$62.53
$19.91
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$39.33
$21.00
AVG Volume (30 Days)
626.9K
1.1M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
0.41
N/A
Revenue
$79,950,000.00
$255,869,000.00
Revenue This Year
$40.90
$0.76
Revenue Next Year
$47.23
$4.60
P/E Ratio
$152.73
N/A
Revenue Growth
104.94
23.29
52 Week Low
$14.27
$10.95
52 Week High
$66.37
$23.02

Technical Indicators

Market Signals
Indicator
ETON
SDGR
Relative Strength Index (RSI) 70.36 64.23
Support Level $15.66 $17.23
Resistance Level N/A N/A
Average True Range (ATR) 3.41 0.82
MACD 0.75 0.11
Stochastic Oscillator 86.65 80.42

Price Performance

Historical Comparison
ETON
SDGR

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: